Virus vs. cancer: early trial tests direct tumor injection
NCT ID NCT05938296
Summary
This early-stage study is testing the safety of a modified virus called BS006, which is injected directly into tumors. It aims to see if the virus can help the body's immune system fight advanced solid tumors in patients who have already tried standard treatments. The study is currently suspended and was enrolling adults with certain measurable tumors, like melanoma or skin cancer, that can be felt or seen on an ultrasound.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Barbara Ann Karmanos Cancer Hospital dba Karmanos Cancer Center
Detroit, Michigan, 48201, United States
-
Orlando Health Cancer Institute
Orlando, Florida, 32806, United States
Conditions
Explore the condition pages connected to this study.